综合医院环境下酒精戒断综合征的管理
本文为临床聚焦综述,概述综合医院人群中酒精戒断的流行病学、病理生理、临床表现、筛查、评估与治疗,重点总结苯二氮䓬类药物、苯巴比妥、抗癫痫药及α-2肾上腺素能药物的住院治疗研究,并指出新型生物标志物、风险分层工具及非苯二氮䓬策略等新兴方向。
要点
- 临床医生需识别、评估、风险分层并治疗酒精戒断。
- 药物治疗综述聚焦苯二氮䓬类、苯巴比妥、抗癫痫药及α-2肾上腺素能药物。
- 新兴方向包括新型酒精生物标志物、风险分层工具及非症状触发方案。
核心结论
- 临床医生需准备好识别、评估、风险分层并以循证干预治疗酒精戒断。
- 需确定哪些人群将从非苯二氮䓬策略中获益,并采用更个体化的风险分层方法指导治疗。
- 未来研究应更大程度纳入性别及种族和族裔少数群体。
研究设计与样本
- 临床聚焦综述,总结住院人群中酒精戒断综合征的药物治疗研究。
主要发现
- 新冠大流行与酒精消费及包括酒精戒断住院在内的相关发病率空前增加相关。
- 药物治疗综述聚焦苯二氮䓬类药物、苯巴比妥、抗癫痫药及α-2肾上腺素能药物。
- 新兴关注领域包括新型酒精生物标志物、风险分层工具、替代症状严重程度量表、对苯二氮䓬类药物耐药的严重戒断综合征及治疗协议变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The covid-19 pandemic was associated with an unprecedented increase in alcohol consumption and associated morbidity, including hospitalizations for alcohol withdrawal. Clinicians based in hospitals must be ready to identify, assess, risk-stratify, and treat alcohol withdrawal with evidence based interventions. In this clinically focused review, we outline the epidemiology, pathophysiology, clinical manifestations, screening, assessment, and treatment of alcohol withdrawal in the general hospital population. We review and summarize studies addressing the drug treatment of alcohol withdrawal syndromes in inpatient populations, with a focus on the use of benzodiazepine drugs, phenobarbital, antiseizure drugs, and α-2 adrenergic drugs. Emerging areas of interest include the use of novel alcohol biomarkers, risk stratification instruments, alternative symptom severity scales, severe withdrawal syndromes resistant to benzodiazepine drugs, and treatment protocol variations-including non-symptom-triggered and benzodiazepine-sparing protocols. We identify key areas for research including identification of populations who will benefit from non-benzodiazepine strategies, more individualized risk stratification approaches to guide treatment, and greater inclusion of gender and racial and ethnic minorities in future studies.
引用
- Kast KA, Sidelnik SA, Nejad SH, et al. Management of alcohol withdrawal syndromes in general hospital settings. BMJ. 2025. PMID: 39778965. doi:10.1136/bmj-2024-080461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。